Literature DB >> 3282455

Complement: function and clinical relevance.

L W Williams1, A W Burks, R W Steele.   

Abstract

There is a remarkable array of proteins participating in the complement cascade, regulating the activation of the system, or recognizing a fragment of a component as a biologic signal. The classical pathway of complement activation depends on antigen-antibody interaction and is important as an effector arm of acquired humoral immunity to microorganisms. The alternative pathway functions as a form of innate humoral immunity by attacking membranes not having the characteristics of self-membrane. In addition, the alternative path provides amplification after triggering by either path. Absence or dysfunction of many of the components is associated with autoimmune or immunodeficiency disease. Absence of the inhibitor C1INH is associated with the unique syndrome of hereditary angioedema.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282455

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  4 in total

1.  Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.

Authors:  I J Messias-Reason; S Y Hayashi; R M Nisihara; M Kirschfink
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

Authors:  C S Rinder; H M Rinder; B R Smith; J C Fitch; M J Smith; J B Tracey; L A Matis; S P Squinto; S A Rollins
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

3.  Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families.

Authors:  O Sanal; M Loos; F Ersoy; G Kanra; G Seçmeer; I Tezcan
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

4.  Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.

Authors:  Aldacilene Souza Silva; Anderson Gustavo Teixeira; Lorena Bavia; Fabio Lin; Roberta Velletri; Rubens Belfort; Lourdes Isaac
Journal:  Mol Vis       Date:  2012-08-30       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.